×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CNTA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/11
07:31 am
cnta
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications [Yahoo! Finance]
Medium
Report
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications [Yahoo! Finance]
12/11
07:00 am
cnta
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications
Medium
Report
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications
12/10
08:43 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $62.00 price target on the stock.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $62.00 price target on the stock.
12/9
12:27 am
cnta
Analysts Boost Centessa Pharmaceuticals plc (CNTA) Price Targets as Sleep Disorder Drug Shows Breakthrough Results [Yahoo! Finance]
Low
Report
Analysts Boost Centessa Pharmaceuticals plc (CNTA) Price Targets as Sleep Disorder Drug Shows Breakthrough Results [Yahoo! Finance]
12/1
10:19 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at B. Riley from $33.00 to $42.00. They now have a "buy" rating on the stock.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at B. Riley from $33.00 to $42.00. They now have a "buy" rating on the stock.
11/21
05:30 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
11/18
10:00 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at Guggenheim from $28.00 to $43.00. They now have a "buy" rating on the stock.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at Guggenheim from $28.00 to $43.00. They now have a "buy" rating on the stock.
11/14
08:21 pm
cnta
Centessa (CNTA) Hits All-Time High on New $287-Million Fundraising Program [Yahoo! Finance]
Low
Report
Centessa (CNTA) Hits All-Time High on New $287-Million Fundraising Program [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
8/12/2025
07:00 am
cnta
centessa pharmaceuticals plc - american depositary shares
MISS
Report
-4.7%
centessa pharmaceuticals plc - american depositary shares
5/14/2025
07:00 am
cnta
centessa pharmaceuticals plc - american depositary shares
BEAT
Report
-1.1%
centessa pharmaceuticals plc - american depositary shares
3/24/2025
07:00 am
cnta
centessa pharmaceuticals plc - american depositary shares
MISS
Report
5.8%
centessa pharmaceuticals plc - american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/11
07:52 am
cnta
Form 8-K Centessa Pharmaceuticals For: Dec 05
Low
Report
Form 8-K Centessa Pharmaceuticals For: Dec 05
12/9
07:08 pm
cnta
Form 4 Centessa Pharmaceuticals For: Dec 09 Filed by: Accardi Mario Alberto
Medium
Report
Form 4 Centessa Pharmaceuticals For: Dec 09 Filed by: Accardi Mario Alberto
12/9
04:39 pm
cnta
Form 144 Centessa Pharmaceuticals Filed by: Accardi Mario Alberto
Medium
Report
Form 144 Centessa Pharmaceuticals Filed by: Accardi Mario Alberto
12/8
06:26 pm
cnta
Form 4 Centessa Pharmaceuticals For: Dec 08 Filed by: Accardi Mario Alberto
Low
Report
Form 4 Centessa Pharmaceuticals For: Dec 08 Filed by: Accardi Mario Alberto
12/8
04:06 pm
cnta
Form 144 Centessa Pharmaceuticals Filed by: Accardi Mario Alberto
Medium
Report
Form 144 Centessa Pharmaceuticals Filed by: Accardi Mario Alberto
11/28
05:12 pm
cnta
Form SCHEDULE 13D/A Centessa Pharmaceuticals Filed by: General Atlantic Cooperatief U.A.
Low
Report
Form SCHEDULE 13D/A Centessa Pharmaceuticals Filed by: General Atlantic Cooperatief U.A.
11/24
11:16 am
cnta
Form 8-K Centessa Pharmaceuticals For: Nov 24
Low
Report
Form 8-K Centessa Pharmaceuticals For: Nov 24
11/24
11:16 am
cnta
Form 424B5 Centessa Pharmaceuticals
Low
Report
Form 424B5 Centessa Pharmaceuticals
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: